Cornerstone Robotics and Medtronic Expand Global Surgical Robotics Partnership with US$700 Million Investment

Cornerstone Robotics, an innovative surgical robotics company founded and headquartered in Hong Kong, today hosted the inaugural Surgical Futures Forum at ...

November 11, 2026 | Wednesday | News
Essential Pharma and Nordmark Partner to Launch UK-Approved Norzyme for Pancreatic Exocrine Insufficiency

Partnership brings together decades of pancreatin experience at Nordmark and Essential Pharma Norzyme® (pancreas powder) 25,000 gastro-resistant capsu...

November 10, 2026 | Tuesday | News
iDEL Therapeutics and Daiichi Sankyo Partner to Develop Multi-Drug Conjugates for Solid Tumours

iDEL Therapeutics announced that it has entered into a research collaboration with Daiichi Sankyo (TSE: 4568) to utilize iDEL’s synthetic shuttl...

November 10, 2026 | Tuesday | News
MRM Health and Biocodex Partner on €15 Million Manufacturing Facility for Microbiome-Based Medicines

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines Collaboration c...

November 06, 2026 | Friday | News
Boehringer Ingelheim and Sino Biopharmaceutical Sign Potential US$7.36 Billion Oncology Licensing Deal

Partnership provides opportunities to further expand Boehringer Ingelheim’s portfolio of antibody-drug conjugates (ADCs) and T-cell engagers (TcEs)...

November 05, 2026 | Thursday | News
Ambrose Healthcare’s Rare Disease Strategy: Reviving Promising Therapies Through Strategic Acquisitions

Ambrose Healthcare’s acquisition of AM-Pharma, valued at up to €161 million plus royalties, strengthens its rare disease pipeline and establishe...

November 04, 2026 | Wednesday | Interview
Blackstone Life Sciences and Boston Scientific Announce US$455 Million Collaboration to Develop VITALYST Heart Pump

Blackstone Life Sciences (“BXLS”) announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the developm...

November 04, 2026 | Wednesday | News
Rhythm Pharmaceuticals Secures US$750 Million Financing and Amends LG Chem Obesity Drug Licensing Agreement

Amendment revised royalty structure from low-to-mid-single digits to 1% on global net sales of Rhythm MC4R agonists, including setmelanotide, bivamelagon a...

November 04, 2026 | Wednesday | News
Idorsia and Nxera Pharma Partner to Advance Lucerastat into Phase 3 Trials for Fabry Disease

FAB-KLEAR investigates lucerastat as a potential disease-modifying therapy targeting the kidney manifestations of Fabry disease. Nxera will contribute to ...

October 29, 2026 | Thursday | News
American Hospital Dubai Partners with HEI Global Health to Develop AI-Powered Revenue Cycle Platform

American Hospital Dubai ("AHD"), one of the Middle East's premier private healthcare providers and a member of the Mayo Clinic Care Network, and HEI Global...

October 27, 2026 | Tuesday | News
BioNTech and Gilead Partner to Evaluate Pumitamig and Trodelvy in Phase 3 Breast Cancer Trial

BioNTech enters a clinical trial collaboration with Gilead Sciences with the aim of improving outcomes in patients with PD-L1 low or negative triple-nega...

October 23, 2026 | Friday | News
Okomera Partners with Servier to Advance Cancer Drug Development Using Tumour Modelling Technology

Okomera reaches a key milestone in its industrial rollout with the first commercial installation of its integrated platform, combining hardware, softwa...

October 22, 2026 | Thursday | News
Ambrose Healthcare Acquires AM-Pharma in Deal Worth Up to €161 Million

Ambrose Healthcare, a rare disease specialist, has acquired 100% of the shares of AM-Pharma. Under the terms of the agreement, AM-Pharma's shareholders are...

October 21, 2026 | Wednesday | News
Zealand Pharma Expands Beyond Peptides in $1.2 Billion Generate Collaboration

Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multis...

October 15, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close